{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:17:35Z","timestamp":1779279455612,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11102-026-01644-2","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:52:09Z","timestamp":1773895929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic syndrome in cushing\u2019s syndrome patients: Does gender matter?"],"prefix":"10.1007","volume":"29","author":[{"given":"Francesco","family":"Ferra\u00f9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Acanfora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Pirchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Verrienti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Sofia","family":"Blanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Frara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Auriemma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"1644_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02758-3","author":"F Ceccato","year":"2025","unstructured":"Ceccato F, Terzolo M, Gatto F, Cannav\u00f2 S, Bianchi A, Isidori AM, Colao A, Ferone D, Aimaretti G, Pecori Giraldi F, Arnaldi G, Scaroni C (2025) Who and how to screen for cushing\u2019s syndrome: the position statement of the Italian society of endocrinology. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-025-02758-3","journal-title":"J Endocrinol Invest"},{"key":"1644_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf088","author":"O Suntornlohanakul","year":"2025","unstructured":"Suntornlohanakul O, Ronchi CL, Arlt W, Prete A (2025) Sexual dimorphism in benign adrenocortical tumours. Eur J Endocrinol. https:\/\/doi.org\/10.1093\/ejendo\/lvaf088","journal-title":"Eur J Endocrinol"},{"key":"1644_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00100-0","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein T, Reimondo G, Di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol. https:\/\/doi.org\/10.1016\/S2213-8587(22)00100-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1644_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2013.10.005","author":"EB Geer","year":"2014","unstructured":"Geer EB, Islam J, Buettner C (2014) Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am. https:\/\/doi.org\/10.1016\/j.ecl.2013.10.005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1644_CR5","doi-asserted-by":"publisher","DOI":"10.1159\/000486002","author":"F Ferra\u00f9","year":"2018","unstructured":"Ferra\u00f9 F, Korbonits M (2018) Metabolic syndrome in cushing\u2019s syndrome patients. Front Horm Res. https:\/\/doi.org\/10.1159\/000486002","journal-title":"Front Horm Res"},{"key":"1644_CR6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae517","author":"F Ceccato","year":"2025","unstructured":"Ceccato F, Bavaresco A, Ragazzi E, Barbot M, Boscaro M, Basso D, Scaroni C, Antonelli G (2025) Clinical and biochemical data for the diagnosis of endogenous hypercortisolism: the cushingomic approach. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae517","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR7","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac379","author":"LT Braun","year":"2022","unstructured":"Braun LT, Vogel F, Zopp S, Marchant Seiter T, Rubinstein G, Berr CM, K\u00fcnzel H, Beuschlein F, Reincke M (2022) Whom should we screen for Cushing syndrome? The endocrine society practice guideline recommendations 2008 revisited. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgac379","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03829.x","author":"EB Geer","year":"2010","unstructured":"Geer EB, Shen W, Gallagher D, Punyanitya M, Looker HC, Post KD, Freda PU (2010) MRI assessment of lean and adipose tissue distribution in female patients with cushing\u2019s disease. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03829.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12644","author":"LG Libuit","year":"2015","unstructured":"Libuit LG, Karageorgiadis AS, Sinaii N, Nguyen May NM, Keil MF, Lodish MB, Stratakis CA (2015) A gender-dependent analysis of cushing\u2019s disease in childhood: pre- and postoperative follow-up. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.12644","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12299","author":"M Zilio","year":"2014","unstructured":"Zilio M, Barbot M, Ceccato F, Camozzi V, Bilora F, Casonato A, Frigo AC, Albiger N, Daidone V, Mazzai L, Mantero F, Scaroni C (2014) Diagnosis and complications of cushing\u2019s disease: gender-related differences. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.12299","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR11","doi-asserted-by":"publisher","DOI":"10.3233\/BME-141168","author":"C Huan","year":"2014","unstructured":"Huan C, Qu Y, Ren Z (2014) Gender differences in presentation and outcome of patients with cushing\u2019s disease in Han Chinese. Biomed Mater Eng. https:\/\/doi.org\/10.3233\/BME-141168","journal-title":"Biomed Mater Eng"},{"key":"1644_CR12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021518","author":"F Pecori Giraldi","year":"2003","unstructured":"Pecori Giraldi F, Moro M, Cavagnini F, Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of Endocrinology (2003) Gender-related differences in the presentation and course of Cushing\u2019s disease. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2002-021518","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/949620","author":"X Liu","year":"2015","unstructured":"Liu X, Zhu X, Zeng M, Zhuang Y, Zhou Y, Zhang Z, Yang Y, Wang Y, Ye H, Li Y (2015) Gender-specific differences in clinical profile and biochemical parameters in patients with cushing\u2019s disease: a single center experience. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2015\/949620","journal-title":"Int J Endocrinol"},{"issue":"22","key":"1644_CR14","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.3760\/cma.j.issn.0366-6999.20141982","volume":"127","author":"Y Chen","year":"2014","unstructured":"Chen Y, Mei X, Jian F, Ma Q, Chen X, Bian L, Sun Q (2014) Gender and magnetic resonance imaging classification-related differences in clinical and biochemical characteristics of cushing\u2019s disease: a single-centre study. Chin Med J (Engl) 127(22):3948\u20133956","journal-title":"Chin Med J (Engl)"},{"key":"1644_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3123","author":"EB Geer","year":"2012","unstructured":"Geer EB, Shen W, Strohmayer E, Post KD, Freda PU (2012) Body composition and cardiovascular risk markers after remission of Cushing\u2019s disease: a prospective study using whole-body MRI. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2011-3123","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR16","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490561","author":"AG Rockall","year":"2003","unstructured":"Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH (2003) Computed tomography assessment of fat distribution in male and female patients with cushing\u2019s syndrome. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje.0.1490561","journal-title":"Eur J Endocrinol"},{"key":"1644_CR17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0272","author":"E Valassi","year":"2011","unstructured":"Valassi E, Santos A, Yaneva M, T\u00f3th M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM, ERCUSYN Study Group (2011) The European registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-11-0272","journal-title":"Eur J Endocrinol"},{"key":"1644_CR18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0754","author":"C Giordano","year":"2013","unstructured":"Giordano C, Guarnotta V, Pivonello R, Amato MC, Simeoli C, Ciresi A, Cozzolino A, Colao A (2013) Is diabetes in cushing\u2019s syndrome only a consequence of hypercortisolism? Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-13-0754","journal-title":"Eur J Endocrinol"},{"key":"1644_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02168.x","author":"T Mancini","year":"2004","unstructured":"Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G (2004) High cardiovascular risk in patients with Cushing\u2019s syndrome according to 1999 WHO\/ISH guidelines. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02168.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvae114","author":"C Padilla","year":"2024","unstructured":"Padilla C, Stratakis CA, Tatsi C (2024) The phenotype of the pediatric patient with Cushing syndrome but without obesity. Eur J Endocrinol. https:\/\/doi.org\/10.1093\/ejendo\/lvae114","journal-title":"Eur J Endocrinol"},{"key":"1644_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00580","author":"LHA Broersen","year":"2019","unstructured":"Broersen LHA, van Haalen FM, Kienitz T, Biermasz NR, Strasburger CJ, Dekkers OM, Pereira AM (2019) Sex differences in presentation but not in outcome for ACTH-Dependent cushing\u2019s syndrome. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2019.00580","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1644_CR22","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2013-0068","author":"V Vicennati","year":"2014","unstructured":"Vicennati V, Garelli S, Rinaldi E, Di Dalmazi G, Pagotto U, Pasquali R (2014) Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic States. Horm Mol Biol Clin Investig. https:\/\/doi.org\/10.1515\/hmbci-2013-0068","journal-title":"Horm Mol Biol Clin Investig"},{"key":"1644_CR23","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.11.8059","author":"GG Garrapa","year":"2001","unstructured":"Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E (2001) Body composition and metabolic features in women with adrenal incidentaloma or cushing\u2019s syndrome. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.86.11.8059","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.3.8321","author":"M Pirlich","year":"2002","unstructured":"Pirlich M, Biering H, Gerl H, Ventz M, Schmidt B, Ertl S, Lochs H (2002) Loss of body cell mass in cushing\u2019s syndrome: effect of treatment. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.87.3.8321","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0747","author":"O Ragnarsson","year":"2015","unstructured":"Ragnarsson O, Glad CA, Bergthorsdottir R, Almqvist EG, Ekerstad E, Widell H, W\u00e4ngberg B, Johannsson G (2015) Body composition and bone mineral density in women with cushing\u2019s syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-14-0747","journal-title":"Eur J Endocrinol"},{"key":"1644_CR26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0766","author":"MJ Barahona","year":"2009","unstructured":"Barahona MJ, Sucunza N, Resmini E, Fern\u00e1ndez-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J, Webb SM (2009) Persistent body fat mass and inflammatory marker increases after long-term cure of cushing\u2019s syndrome. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2009-0766","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12639","author":"M Wagenmakers","year":"2015","unstructured":"Wagenmakers M, Roerink S, Gil L, Plantinga T, Smit J, Netea-Maier R, Hermus A (2015) Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of cushing\u2019s syndrome. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.12639","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.10.4284","author":"JM Elbers","year":"1997","unstructured":"Elbers JM, Asscheman H, Seidell JC, Fr\u00f6lich M, Meinders AE, Gooren LJ (1997) Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.82.10.4284","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR29","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.6.913","author":"V Van Harmelen","year":"1998","unstructured":"Van Harmelen V, Reynisdottir S, Eriksson P, Th\u00f6rne A, Hoffstedt J, L\u00f6nnqvist F, Arner P (1998) Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. https:\/\/doi.org\/10.2337\/diabetes.47.6.913","journal-title":"Diabetes"},{"key":"1644_CR30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.6.4849","author":"X Casabiell","year":"1998","unstructured":"Casabiell X, Pi\u00f1eiro V, Peino R, Lage M, Cami\u00f1a J, Gallego R, Vallejo LG, Dieguez C, Casanueva FF (1998) Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.83.6.4849","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345137","author":"P Putignano","year":"2003","unstructured":"Putignano P, Brunani A, Dubini A, Bertolini M, Pasquali R, Cavagnini F, Study Group on Obesity of the Italian Society of Endocrinology (2003) Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: a dose-response study. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/BF03345137","journal-title":"J Endocrinol Invest"},{"key":"1644_CR32","doi-asserted-by":"publisher","DOI":"10.1159\/000330416","author":"E Valassi","year":"2012","unstructured":"Valassi E, Biller BM, Klibanski A, Misra M (2012) Adipokines and cardiovascular risk in cushing\u2019s syndrome. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000330416","journal-title":"Neuroendocrinology"},{"key":"1644_CR33","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.2.4566","author":"A Widjaja","year":"1998","unstructured":"Widjaja A, Sch\u00fcrmeyer TH, Von zur M\u00fchlen A, Brabant G (1998) Determinants of serum leptin levels in cushing\u2019s syndrome. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.83.2.4566","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1276-7","author":"V Guarnotta","year":"2018","unstructured":"Guarnotta V, Ciresi A, Pitrone M, Pizzolanti G, Giordano C (2018) Pasireotide versus pituitary surgery: a retrospective analysis of 12 months of treatment in patients with cushing\u2019s disease. Endocrine. https:\/\/doi.org\/10.1007\/s12020-017-1276-7","journal-title":"Endocrine"},{"key":"1644_CR35","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.8.6733","author":"LB Williams","year":"2000","unstructured":"Williams LB, Fawcett RL, Waechter AS, Zhang P, Kogon BE, Jones R, Inman M, Huse J, Considine RV (2000) Leptin production in adipocytes from morbidly obese subjects: stimulation by dexamethasone, Inhibition with troglitazone, and influence of gender. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.85.8.6733","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2003.01987.x","author":"M Krsek","year":"2004","unstructured":"Krsek M, Silha JV, Jezkov\u00e1 J, H\u00e1na V, Marek J, Weiss V, Step\u00e1n JJ, Murphy LJ (2004) Adipokine levels in cushing\u2019s syndrome; elevated resistin levels in female patients with cushing\u2019s syndrome. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2003.01987.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR37","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-814457","author":"F Fallo","year":"2004","unstructured":"Fallo F, Mulatero P, Vettor R, Scarda A, Della Mea P, Morello F, Veglio F, Williams TA (2004) Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients. Horm Metab Res. https:\/\/doi.org\/10.1055\/s-2004-814457","journal-title":"Horm Metab Res"},{"key":"1644_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02169.x","author":"R Lib\u00e8","year":"2005","unstructured":"Lib\u00e8 R, Morpurgo PS, Cappiello V, Maffini A, Bondioni S, Locatelli M, Zavanone M, Beck-Peccoz P, Spada A (2005) Ghrelin and adiponectin in patients with cushing\u2019s disease before and after successful transsphenoidal surgery. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02169.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR39","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0354","author":"F Ferra\u00f9","year":"2015","unstructured":"Ferra\u00f9 F, Korbonits M (2015) Metabolic comorbidities in cushing\u2019s syndrome. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-15-0354","journal-title":"Eur J Endocrinol"},{"key":"1644_CR40","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2024.55","author":"BF Alqeeq","year":"2024","unstructured":"Alqeeq BF, Ayyad M, Almadhoun WJ, Aboabdo M, Aldahdouh MS, Al-Tawil M, Al-Ghazali AM (2024) Sex-related differences in cushing\u2019s disease: a systematic review and meta-analysis. Ann Saudi Med. https:\/\/doi.org\/10.5144\/0256-4947.2024.55","journal-title":"Ann Saudi Med"},{"key":"1644_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2019.08.005","author":"LK Nieman","year":"2019","unstructured":"Nieman LK (2019) Hypertension and cardiovascular Val in patients with Cushing syndrome. Endocrinol Metab Clin North Am. https:\/\/doi.org\/10.1016\/j.ecl.2019.08.005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1644_CR42","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac265","author":"P Limumpornpetch","year":"2022","unstructured":"Limumpornpetch P, Morgan AW, Tiganescu A, Baxter PD, Nyawira Nyaga V, Pujades-Rodriguez M, Stewart PM (2022) The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgac265","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1270455","author":"A Jurek","year":"2023","unstructured":"Jurek A, Krzesi\u0144ski P, Uzi\u0119b\u0142o-\u017byczkowska B, Witek P, Zieli\u0144ski G, Kazimierczak A, Wierzbowski R, Banak M, Gielerak G (2023) The patient\u2019s sex determines the hemodynamic profile in patients with Cushing disease. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2023.1270455","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1644_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04206.x","author":"PM Toja","year":"2012","unstructured":"Toja PM, Branzi G, Ciambellotti F, Radaelli P, De Martin M, Lonati LM, Scacchi M, Parati G, Cavagnini F, Pecori Giraldi F (2012) Clinical relevance of cardiac structure and function abnormalities in patients with Cushing\u2019s syndrome before and after cure. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04206.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.777964","author":"S Miao","year":"2021","unstructured":"Miao S, Lu L, Li L, Wang Y, Lu Z, Zhu H, Wang L, Duan L, Xing X, Yao Y, Feng M, Wang R (2021) Clinical characteristics for the improvement of Cushing\u2019s syndrome complicated with cardiomyopathy after treatment with a literature review. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.777964","journal-title":"Front Cardiovasc Med"},{"key":"1644_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117270","author":"KB Holven","year":"2023","unstructured":"Holven KB, van Roeters Lennep J (2023) Sex differences in lipids: a life course approach. Atherosclerosis. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117270","journal-title":"Atherosclerosis"},{"key":"1644_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000330","author":"J Bor\u00e9n","year":"2016","unstructured":"Bor\u00e9n J, Williams KJ (2016) The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. https:\/\/doi.org\/10.1097\/MOL.0000000000000330","journal-title":"Curr Opin Lipidol"},{"key":"1644_CR48","doi-asserted-by":"publisher","DOI":"10.2174\/0115701611272145231106053914","author":"P Poredos","year":"2023","unstructured":"Poredos P, Schernthaner GH, Blinc A, Mikhailidis DP, Jensterle M, Anagnostis P, Antignani PL, Studen KB, \u0160abovi\u0107 M, Jezovnik MK (2023) Endocrine disorders and peripheral arterial disease - a series of reviews Cushing Syndrome-Cortisol excess. Curr Vasc Pharmacol. https:\/\/doi.org\/10.2174\/0115701611272145231106053914","journal-title":"Curr Vasc Pharmacol"},{"key":"1644_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120185","author":"A Aulinas","year":"2015","unstructured":"Aulinas A, Ram\u00edrez MJ, Barahona MJ, Valassi E, Resmini E, Mato E, Santos A, Crespo I, Bell O, Surrall\u00e9s J, Webb SM (2015) Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing\u2019s syndrome. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0120185","journal-title":"PLoS One"},{"key":"1644_CR50","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.8.5896","author":"A Colao","year":"1999","unstructured":"Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.84.8.5896","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101667","author":"CB Newman","year":"2023","unstructured":"Newman CB (2023) Effects of endocrine disorders on lipids and lipoproteins. Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.beem.2022.101667","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1644_CR52","doi-asserted-by":"publisher","DOI":"10.1159\/000314213","author":"G Arnaldi","year":"2010","unstructured":"Arnaldi G, Scandali VM, Trementino L et al (2010) Pathophysiology of dyslipidemia in cushing\u2019s syndrome. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000314213","journal-title":"Neuroendocrinology"},{"key":"1644_CR53","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2015-2080","author":"S Hescot","year":"2015","unstructured":"Hescot S, Seck A, Guerin M et al (2015) Lipoprotein-free mitotane exerts high cytotoxic activity in adrenocortical carcinoma. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/JC.2015-2080","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR54","doi-asserted-by":"publisher","DOI":"10.1159\/000314294","author":"Y Greenman","year":"2010","unstructured":"Greenman Y (2010) Management of dyslipidemia in cushing\u2019s syndrome. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000314294","journal-title":"Neuroendocrinology"},{"key":"1644_CR55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2813","author":"ST Page","year":"2012","unstructured":"Page ST, Krauss RM, Gross C et al (2012) Impact of mifepristone, a glucocorticoid\/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2011-2813","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12431","author":"R Pivonello","year":"2014","unstructured":"Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM, Pasireotide BSG (2014) Pasireotide treatment significantly improves clinical signs and symptoms in patients with cushing\u2019s disease: results from a phase III study. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.12431","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1644_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13175","author":"RN Clayton","year":"2022","unstructured":"Clayton RN (2022) Cardiovascular complications of cushings syndrome: impact on morbidity and mortality. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.13175","journal-title":"J Neuroendocrinol"},{"key":"1644_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13114","author":"E Valassi","year":"2022","unstructured":"Valassi E (2022) Clinical presentation and etiology of cushing\u2019s syndrome: data from ERCUSYN. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.13114","journal-title":"J Neuroendocrinol"},{"key":"1644_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00222","author":"B B\u0142o-\u017byczkowska","year":"2017","unstructured":"B\u0142o-\u017byczkowska B, Krzesin\u0144ski P, Witek P, Zielin\u0144ski G, Jurek A, Gielerak G, Skrobowski A (2017) Cushing\u2019s disease: subclinical left ventricular systolic and diastolic dysfunction revealed by speckle tracking echocardiography and tissue doppler imaging. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2017.00222","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1644_CR60","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab556","author":"P Wolf","year":"2021","unstructured":"Wolf P, Marty B, Bouazizi K, Kachenoura N, Piedvache C, Blanchard A, Salenave S, Prigent M, Jublanc C, Ajzenberg C, Droumaguet C, Young J, Lecoq AL, Kuhn E, Agostini H, Trabado S, Carlier PG, F\u00e8ve B, Redheuil A, Chanson P, Kamenick\u00fd P (2021) Epicardial and pericardial adiposity without myocardial steatosis in Cushing syndrome. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgab556","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01644-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01644-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01644-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:01:39Z","timestamp":1779278499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01644-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01644-2","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}